The latest closing stock price for AN2 Therapeutics as of April 01, 2025 is 1.38.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2015 would have $-970 today, roughly -1 times their original investment - a -29.50% compound annual growth rate over 10 years.
The all-time high AN2 Therapeutics stock closing price was 61.75 on January 26, 2018.
The AN2 Therapeutics 52-week high stock price is 3.54, which is 156.5% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 37% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 1.63.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2015 would have $-970 today, roughly -1 times their original investment - a -29.50% compound annual growth rate over 10 years.
The all-time high AN2 Therapeutics stock closing price was 61.75 on January 26, 2018.
The AN2 Therapeutics 52-week high stock price is 3.54, which is 156.5% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 37% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 1.63.